Denosumab Versus Oral Bisphosphonate (Alendronate) for Osteoporosis in Long-term Glucocorticoid Users: an Open Randomized Controlled Trial
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism
- 11 Feb 2020 Status changed from active, no longer recruiting to completed.
- 02 Sep 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Oct 2019.